APA

Bergman A. M., Eijk P. P., Ruiz van Haperen V. W. T., Smid K., Veerman G., Hubeek I., van den Ijssel P., Ylstra B. & Peters G. J. (20051219). In vivo induction of resistance to gemcitabine results in increased expression of ribonucleotide reductase subunit M1 as the major determinant. : Cancer research.

Chicago

Bergman Andries M, Eijk Paul P, Ruiz van Haperen Veronique W T, Smid Kees, Veerman Gijsbert, Hubeek Isabelle, van den Ijssel Paul, Ylstra Bauke and Peters Godefridus J. 20051219. In vivo induction of resistance to gemcitabine results in increased expression of ribonucleotide reductase subunit M1 as the major determinant. : Cancer research.

Harvard

Bergman A. M., Eijk P. P., Ruiz van Haperen V. W. T., Smid K., Veerman G., Hubeek I., van den Ijssel P., Ylstra B. and Peters G. J. (20051219). In vivo induction of resistance to gemcitabine results in increased expression of ribonucleotide reductase subunit M1 as the major determinant. : Cancer research.

MLA

Bergman Andries M, Eijk Paul P, Ruiz van Haperen Veronique W T, Smid Kees, Veerman Gijsbert, Hubeek Isabelle, van den Ijssel Paul, Ylstra Bauke and Peters Godefridus J. In vivo induction of resistance to gemcitabine results in increased expression of ribonucleotide reductase subunit M1 as the major determinant. : Cancer research. 20051219.